Appendix Table II.
Lymphoma Subtype | No. Subjects (with stage) | Average Age (yrs) | Gender |
---|---|---|---|
CD8+ | 2 (both IB) | 63.5 | 2F |
CD30+ | 2 (IB, IIB) | 57.5 | 2M |
Non-Hodgkins | 2 (IB, III) | 68 | 2M |
Peripheral T cell | 1 (deceased) | 74 | 1F |
Totals | 7 | 65.75 | 3F/4M |
Controls | 35 | 59.7 | 13F/22M |
According to the World Health Organization (WHO) and the European Organization for Research and Treatment of Cancer (EORTC) combined staging classification. Table depicts patients’ stage at the time of enrollment.